Eye (2015) 29, 1640 © 2015 Macmillan Publishers Limited All rights reserved 0950-222X/15 www.nature.com/eye
CORRIGENDUM
The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary
S Sivaprasad, WM Amoaku, P Hykin and RVO Guideline Group
Eye (2015) 29, 1640; doi:10.1038/eye.2015.237
to the use of ranibizumab in the treatment of macular oedema secondary to RVO and not TA238. This was a typographical error that the authors accept and hereby correct.
Correction to: Eye (2015) 29, 1633–1638; doi: 10.1038/eye.2015.164; published online 28 August 2015
The authors would like to apologise for this error. Since the online publication of this paper, the authors have been made aware of an error (as referenced in the recently published letter by Dr Ting). The authors agree with the letter that TA283 is the relevant NICE Guidance in relation
This error has now been rectified, and the corrected article appears in this issue. The html and online pdf versions have also been rectified, and now carry the corrected paper.
CORRIGENDUM
The Royal College of Ophthalmologists Guidelines on retinal vein occlusions: executive summary
S Sivaprasad, WM Amoaku, P Hykin and RVO Guideline Group
Eye (2015) 29, 1640; doi:10.1038/eye.2015.237
to the use of ranibizumab in the treatment of macular oedema secondary to RVO and not TA238. This was a typographical error that the authors accept and hereby correct.
Correction to: Eye (2015) 29, 1633–1638; doi: 10.1038/eye.2015.164; published online 28 August 2015
The authors would like to apologise for this error. Since the online publication of this paper, the authors have been made aware of an error (as referenced in the recently published letter by Dr Ting). The authors agree with the letter that TA283 is the relevant NICE Guidance in relation
This error has now been rectified, and the corrected article appears in this issue. The html and online pdf versions have also been rectified, and now carry the corrected paper.
